Tadalafil Tablet
Product Images NDC 71335-1670

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 71335-1670). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl713351670)

Label for Tadalafil 10 mg tablet, an oral prescription drug packaged by Bryant Ranch Prepack in Burbank, CA. The label indicates it is comparable to Cialis 10 mg tablet by Ajanta Pharma Limited. Package contains 30 tablets. Storage instructions specify room temperature of 20°-25°C (68°-77°F). Includes warnings to keep out of reach of children and displays a barcode along with NDC 71335-1670.*

FDA Label Image

Tadalafil Fig8

A line graph depicting the change from baseline in IPSS total score over a 12-week treatment period comparing Tadalafil 5 mg and placebo. The y-axis represents the change in score, and the x-axis shows duration in weeks. Tadalafil 5 mg shows a greater reduction in score over time compared to placebo, with statistical significance noted at 12 weeks.*

FDA Label Image

Figure1 (Tadalafil Figure1)

A set of four line graphs showing changes in blood pressure over time. The graphs depict differences between Tadalafil and placebo in standing systolic and diastolic blood pressure, and supine systolic and diastolic blood pressure, measured in mmHg over a 96-hour period.*

FDA Label Image

Figure2 (Tadalafil Figure2)

Two line graphs showing standing and supine systolic blood pressure (mmHg) changes over 24 hours post-dose. The graphs compare effects of Tadalafil 20 mg with doxazosin 8 mg versus placebo with doxazosin 8 mg, illustrating blood pressure changes over time in hours.*

FDA Label Image

Figure3 (Tadalafil Figure3)

A line graph showing the effect of tadalafil and placebo combined with doxazosin on systolic blood pressure (mmHg) over 12 hours. The x-axis represents time after administration, and the y-axis shows changes in systolic BP. Four conditions are plotted with different symbols and line styles indicating morning and evening doses of tadalafil or placebo with doxazosin.*

FDA Label Image

Figure4 (Tadalafil Figure4)

A pharmacokinetic plasma concentration-time graph for Tadalafil showing plasma tadalafil concentration (µg/L) on the y-axis versus time (hours) on the x-axis. The chart compares single 20-mg and 5-mg tadalafil doses and once-daily 5-mg tadalafil following 5 consecutive days of administration, with data points and error bars.*

FDA Label Image

Figure5 (Tadalafil Figure5)

A line graph comparing change from baseline in IPSS total score over 12 weeks of treatment between Tadalafil 5 mg and placebo groups. The x-axis shows treatment duration in weeks, and the y-axis shows change from baseline scores. The graph indicates a greater score reduction with Tadalafil 5 mg compared to placebo, with statistical significance noted (p<0.01).*

FDA Label Image

Figure6 (Tadalafil Figure6)

A line graph comparing change from baseline in IPSS Total Score over 12 weeks between Tadalafil 5 mg and placebo. The x-axis shows treatment duration in weeks, and the y-axis shows the score change. Tadalafil shows a greater decrease, indicating improvement, with statistical significance noted at p<0.01.*

FDA Label Image

Figure7 (Tadalafil Figure7)

A line graph depicting least-squares mean change from baseline over 26 weeks of therapy comparing Tadalafil/Finasteride and Placebo/Finasteride groups. The graph shows changes at 0, 4, 12, and 26 weeks, with Tadalafil/Finasteride showing greater reductions at 4 and 12 weeks, marked by statistical significance (p<0.001 and p<0.05).*

FDA Label Image

Structure (Tadalafil Structure)

Chemical structure of Tadalafil showing its molecular arrangement with multiple rings and functional groups as represented in the labeled diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.